|
|
Article: Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.(Research)(Clinical report)
- Article from:
- Virology Journal
- Article date:
- October 28, 2008
- Author:
CopyrightCOPYRIGHT 2008 BioMed Central Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Authors: Corey J Crevar [1]; Ted M Ross (corresponding author) [1,2]
Introduction
Since re-emerging in 2003, avian influenza viruses of the H5N1 subtype have spread from Southeast Asia across central Asia and the Middle East into Europe and Africa by infecting wild birds and poultry. New influenza viruses and genotypes are emerging each year and are leading to significant genetic variation among H5N1 viruses [1]. Currently, 10 clades of H5N1 isolates have been identified in birds. Recent human isolates have clustered into two distinct clades, clade 1 and clade 2, with clade 2 further being divided into subclades 2.1, 2.2, and 2.3. Although H5N1 remains an avian virus, not ...
Related newspaper, magazine, and journal articles:
|
|
Article: Novavax Completes Enrollment of Its Seasonal Influenza VLP ...
PR Newswire;
September 19, 2008 ;
700+ words
... ... Seasonal influenza VLP vaccine trial enrollment positions ... seasonal influenza VLP vaccine. Specifically, the ... response. Novavax's VLP vaccine may be differentiated ... and cell mediated immune responses to M1 may lead to destruction ...
|
|